| Term 
 | Definition 
 
        | using Phosphotidyl choline plus cholesterol make a rigid spherical bilayer. Phosphtidyl choline plus surfactant make an elastic liposome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Is elastic pass thru filter easier
 smaller
 increase release rate
 less stable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rigid spherical liposome Large than surfactant
 lipid bilayer
 more stable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | measures particle stability |  | 
        |  | 
        
        | Term 
 
        | Salt (co-ions) added to phospholipid |  | Definition 
 
        | can enhance drug loading, ion charge interaction with cell for drug release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | biocompatible because of phospholipid both hydrophobic and hydrophilic
 protect drug
 reduce toxicity
 prolong half life
 use passive and active targeting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stability problems (lipid stability and drug leakage) clearance by MPS
 low drug loading
 poor control of release
 large variation in size
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PEG-Lytaled liposome is hydrophilic to increase MRT to prolong in circulation decrease macrophage recognition
 |  | 
        |  | 
        
        | Term 
 
        | liposome shape for syringe??? |  | Definition 
 
        | spherical and smooth shape sml surface area increases drug release
 |  | 
        |  | 
        
        | Term 
 
        | Nanoparticles via coacervation |  | Definition 
 
        | uses Dextran sulphate -ve chitosan +ve
 opposite charges increase mechanical strength
 safer for water soluble drugs
 acetic acid is the solvent therefore stable
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Charge ratio between DS:CS size: effected by polymer concentration
 increased viscosity by increased concentration
 Drug targeting via homing device on surface
 |  | 
        |  | 
        
        | Term 
 
        | Nanoparticle via evaporation |  | Definition 
 
        | Adv: hydrophobic polymers and hydrophilic drugs Disadv: use organic solvent
 ultrasonic probe can degrade drug and alter particle size (short time use only)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | polymer (DL-lactide) Dichloromethane
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | water poly-vinyl alcohol (stabiliser)
 |  | 
        |  | 
        
        | Term 
 
        | Microcapules via spray drying |  | Definition 
 
        | for hydrophilic and phobic not for heat sensitive drugs
 can trap salt of the drug
 can make suspension or emulsion
 Solvent is water so polymer must be soluble
 Glutaraldehyde is a cross linking agent to albumin to increase stability to make shell hard to control release
 |  | 
        |  |